Homologous recombination–deficient mutation cluster in tumor suppressor <i>RAD51C</i> identified by comprehensive analysis of cancer variants
Rohit Prakash(Medway NHS Foundation Trust), Kara A. Bernstein(Columbia University Irving Medical Center), Tiffany A. Traina(Memorial Sloan Kettering Cancer Center), Raymond Wang(Children's Hospital of Orange County), Michael J. Mihalevic(University of Pittsburgh), Hélène Bret(Lund University), Raphaël Guérois(Université Paris-Sud), Yashpal Rawal(The University of Texas at San Antonio Health Science Center), Jared M. Baird(University of Pittsburgh), Scott H. Kaufmann(Mayo Clinic), Mauro Modesti(Erasmus MC), Hayley L. Rein(University of Pittsburgh), Marc R. Radke(University of Washington), Fang Zhang(Memorial Sloan Kettering Cancer Center), McKenzie K. Grundy(University of Pittsburgh), Elizabeth M. Swisher(University of Washington), Maria Jasin(Memorial Sloan Kettering Cancer Center), Patrick Sung(The University of Texas at San Antonio Health Science Center), Meghan R. Sullivan(University of Pittsburgh), Kristie Darrah(University of Pittsburgh)
Cited by 30
Related Papers
OncoKB: A Precision Oncology Knowledge Base
|JCO Precision Oncology|2017|2.7k
XRCC3 promotes homology-directed repair of DNA damage in mammalian cells
|Genes & Development|1999|1.4k
Repair of Strand Breaks by Homologous Recombination
|Cold Spring Harbor Perspectives in Biology|2013|878
Homologous Recombination and Human Health: The Roles of BRCA1, BRCA2, and Associated Proteins
|Cold Spring Harbor Perspectives in Biology|2015|856
Phase II Trial of Bicalutamide in Patients with Androgen Receptor–Positive, Estrogen Receptor–Negative Metastatic Breast Cancer
|Clinical Cancer Research|2013|744